Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer's disease.
Yu M, Risacher SL, Nho KT, Wen Q, Oblak AL, Unverzagt FW, Apostolova LG, Farlow MR, Brosch JR, Clark DG, Wang S, Deardorff R, Wu YC, Gao S, Sporns O, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative (ADNI). Yu M, et al. Among authors: clark dg. Cell Rep. 2024 Feb 27;43(2):113691. doi: 10.1016/j.celrep.2024.113691. Epub 2024 Jan 19. Cell Rep. 2024. PMID: 38244198 Free PMC article.
Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for Alzheimer's disease.
Swinford CG, Risacher SL, Vosmeier A, Deardorff R, Chumin EJ, Dzemidzic M, Wu YC, Gao S, McDonald BC, Yoder KK, Unverzagt FW, Wang S, Farlow MR, Brosch JR, Clark DG, Apostolova LG, Sims J, Wang DJ, Saykin AJ. Swinford CG, et al. Among authors: clark dg. Neurobiol Aging. 2023 Oct;130:103-113. doi: 10.1016/j.neurobiolaging.2023.06.014. Epub 2023 Jun 28. Neurobiol Aging. 2023. PMID: 37499587
Spatial transcriptomic patterns underlying regional vulnerability to amyloid-β and tau pathologies and their relationships to cognitive dysfunction in Alzheimer's disease.
Yu M, Risacher SL, Nho KT, Wen Q, Oblak AL, Unverzagt FW, Apostolova LG, Farlow MR, Brosch JR, Clark DG, Wang S, Deardorff R, Wu YC, Gao S, Sporns O, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative (ADNI). Yu M, et al. Among authors: clark dg. medRxiv [Preprint]. 2023 Aug 16:2023.08.12.23294017. doi: 10.1101/2023.08.12.23294017. medRxiv. 2023. PMID: 37645867 Free PMC article. Preprint.
BrainAGE Estimation: Influence of Field Strength, Voxel Size, Race, and Ethnicity.
Dempsey DA, Deardorff R, Wu YC, Yu M, Apostolova LG, Brosch J, Clark DG, Farlow MR, Gao S, Wang S, Saykin AJ, Risacher SL; Alzheimer’s Disease Neuroimaging Initiative. Dempsey DA, et al. Among authors: clark dg. medRxiv [Preprint]. 2023 Dec 5:2023.12.05.23299222. doi: 10.1101/2023.12.05.23299222. medRxiv. 2023. PMID: 38106123 Free PMC article. Preprint.
Genome-wide pathway analysis of memory impairment in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks.
Ramanan VK, Kim S, Holohan K, Shen L, Nho K, Risacher SL, Foroud TM, Mukherjee S, Crane PK, Aisen PS, Petersen RC, Weiner MW, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative (ADNI). Ramanan VK, et al. Brain Imaging Behav. 2012 Dec;6(4):634-48. doi: 10.1007/s11682-012-9196-x. Brain Imaging Behav. 2012. PMID: 22865056 Free PMC article.
360 results